Avanos Medical (AVNS) Price to Earnings (2014 - 2026)

Avanos Medical has disclosed Price to Earnings across 13 years of filings, most recently posting 128.21 for Q1 2026.

• In Q1 2026, Price to Earnings rose 27.72% year-over-year to 128.21; the TTM figure through Mar 2026 stood at 8.79 (down 410.16% YoY), while the FY2025 annual figure was 7.16, down 283.48% from the prior year.
• Price to Earnings came in at 128.21 for Q1 2026 at Avanos Medical, up from 401.31 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 508.1 in Q2 2024 to a low of 2775.35 in Q1 2023.
• Average Price to Earnings over 5 years is 190.14, with a median of 64.5 recorded in 2022.
• Year-over-year, Price to Earnings jumped 2990.6% in 2024 and tumbled 21689.8% in 2025.
• Over 5 years, Price to Earnings stood at 74.5 in 2022, then surged by 32.4% to 98.64 in 2023, then plunged by 101.87% to 1.84 in 2024, then plunged by 21689.8% to 401.31 in 2025, then surged by 131.95% to 128.21 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 128.21 in Q1 2026, 401.31 in Q4 2025, and 383.27 in Q3 2025.